Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
309 studies found for:    Open Studies | "Embolism and Thrombosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Embolism and Thrombosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique
Conditions: Intracranial Embolism and Thrombosis;   Postoperative Complications
Intervention: Device: Proximal anastomosis using Heartstring anastomotic device
2 Not yet recruiting Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Conditions: Embolism and Thrombosis of the Radial Artery;   Coronary Heart Disease
Interventions: Device: Glidesheath Slender;   Device: standard 6- French radial sheath
3 Recruiting A Complex Contraception Registry
Conditions: Diabetes;   Cardiovascular Disease;   Epilepsy;   Migraine;   Neurological Disorders;   Cancer;   Bariatric Surgery Candidate;   Organ or Tissue Transplant; Complications;   Lupus Erythematosus, Systemic;   Other Hematologic Conditions;   Other Venous Embolism and Thrombosis
Intervention:
4 Unknown  Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion
Conditions: Intracranial Embolism;   Thrombosis
Intervention: Procedure: transcranial ultrasound in patients treated with iv t-PA
5 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
6 Recruiting Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
7 Recruiting Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
Condition: Sinus Thrombosis, Intracranial
Interventions: Drug: Endovascular thrombolysis;   Drug: Heparin
8 Recruiting Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)
Conditions: Extracorporeal Circulation;   Inflammation;   Blood Coagulation;   Intracranial Embolism
Intervention: Device: MECC system with rheoparin coating
9 Unknown  Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit
Conditions: Coronary Artery Disease;   Acute Cerebrovascular Accident;   Intracranial Embolism;   Embolism, Air
Intervention: Device: ROCsafeTM
10 Recruiting Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
Condition: Symptomatic Superficial Vein Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Placebo
11 Not yet recruiting Cancer Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Cancer
Interventions: Drug: edoxaban;   Drug: Dalteparin
12 Recruiting Registry on WATCHMAN Outcomes in Real-Life Utilization
Condition: Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke
Intervention:
13 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
14 Not yet recruiting Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation
Conditions: Atrial Fibrillation;   Cardioembolic Events;   Oral Anticoagulation
Intervention: Drug: Dabigatran
15 Unknown  Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence
Conditions: Pulmonary Disease, Chronic Obstructive;   Disease Exacerbation;   Pulmonary Embolism;   Prothrombin Fragments
Intervention: Other: CT pulmonary angio, blood tests
16 Unknown  VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
17 Recruiting Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study
Condition: Ileofemoral Deep Vein Thrombosis
Interventions: Drug: rivaroxaban;   Drug: Warfarin
18 Recruiting Nitric Oxide to Treat Pulmonary Embolism
Condition: Pulmonary Embolism
Interventions: Drug: Nitric Oxide;   Drug: Oxygen
19 Recruiting VTEval Project - A Prospective Cohort Study to Evaluate Diagnosis, Management and Outcome in Individuals With Venous Thromboembolism
Conditions: Venous Thromboembolism (VTE);   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE)
Intervention:
20 Recruiting Lung Ultrasound in Pleuritic Chest Pain
Conditions: Community Acquired Pneumonia;   Pleuritis;   Pulmonary Embolism;   Lung Cancer
Intervention: Procedure: Lung ultrasound

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years